These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7812856)

  • 41. Surfactant replacement therapy in newborns with hyaline membrane disease.
    Grobman DW; Foley MM
    Crit Care Nurs Clin North Am; 1992 Sep; 4(3):515-20. PubMed ID: 1388997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in lung injury after combined surfactant and high-frequency ventilation.
    Jackson JC; Truog WE; Standaert TA; Murphy JH; Juul SE; Chi EY; Hildebrandt J; Hodson WA
    Am J Respir Crit Care Med; 1994 Aug; 150(2):534-9. PubMed ID: 8049842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-frequency ventilation compared to conventional positive-pressure ventilation in the treatment of hyaline membrane disease in primates.
    Bell RE; Kuehl TJ; Coalson JJ; Ackerman NB; Null DM; Escobedo MB; Yoder BA; Cornish JD; Nalle L; Skarin RM
    Crit Care Med; 1984 Sep; 12(9):764-8. PubMed ID: 6380939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neonatal extracorporeal life support: impact of new therapies on survival.
    Fliman PJ; deRegnier RA; Kinsella JP; Reynolds M; Rankin LL; Steinhorn RH
    J Pediatr; 2006 May; 148(5):595-9. PubMed ID: 16737868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung protective ventilatory strategies in very low birth weight infants.
    Ramanathan R; Sardesai S
    J Perinatol; 2008 May; 28 Suppl 1():S41-6. PubMed ID: 18446177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bronchopulmonary dysplasia].
    Clément A
    Rev Mal Respir; 1996 Jul; 13(3):243-9. PubMed ID: 8765916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants.
    Namgung R; Lee C; Suh JS; Park KI; Han DG
    Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lung vascular permeability changes in lambs with hyaline membrane disease.
    Sundell HW; Grogaard J; Rojas J; Gray ME; Mohan P; Brigham KL
    J Dev Physiol; 1989 Dec; 12(6):353-62. PubMed ID: 2640230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early and late surfactant treatments in baboon model of hyaline membrane disease.
    Maeta H; Vidyasagar D; Raju TN; Bhat R; Matsuda H
    Pediatrics; 1988 Feb; 81(2):277-83. PubMed ID: 3340477
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The late administration of surfactant.
    Ballot DE; Rothberg AD; Davies VA
    S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The combined effect of prenatal steroid prophylaxis, neonatal surfactant therapy and reduction of risk of complications from respiratory life support on survival rate of very low birthweight infants].
    Görbe E; Jeager J; Kohalmi B; Patkós P; Cziniel M; Sassi L
    Orv Hetil; 2004 Jun; 145(23):1227-32. PubMed ID: 15264590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Childhood pulmonary function following hyaline membrane disease.
    Sheller JR
    Compr Ther; 1990 Oct; 16(10):54-8. PubMed ID: 2249401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High frequency oscillatory ventilation near resonant frequency of the respiratory system in rabbits with normal and surfactant depleted lungs.
    Schulze A; Schaller P; Dinger J; Winkler U; Gmyrek D
    Eur J Pediatr; 1991 Jul; 150(9):671-5. PubMed ID: 1915523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathology of neonatal surfactant deficiency.
    Robertson B
    Perspect Pediatr Pathol; 1987; 11():6-46. PubMed ID: 3110733
    [No Abstract]   [Full Text] [Related]  

  • 56. Pressure-volume curves, static compliances and gas exchange in hyaline membrane disease during conventional mechanical and high-frequency ventilation.
    Pfenninger J; Minder C
    Intensive Care Med; 1988; 14(4):364-72. PubMed ID: 3042826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study.
    Victorin LH; Deverajan LV; Curstedt T; Robertson B
    Biol Neonate; 1990; 58(3):121-6. PubMed ID: 2279046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyaline membrane disease. Effect of surfactant prophylaxis on lung morphology in premature primates.
    Cutz E; Enhörning G; Robertson B; Sherwood WG; Hill DE
    Am J Pathol; 1978 Sep; 92(3):581-94. PubMed ID: 99046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oliguria in the premature baboon with hyaline membrane disease: a manifestation of multisystem immaturity?
    Delemos J; Dryer G; Gerstmann D; Delemos R
    J Perinatol; 1989 Mar; 9(1):19-25. PubMed ID: 2651593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of exogenous surfactant on the development of bronchopulmonary dysplasia in a baboon hyaline membrane disease model.
    Maeta H; Raju TN; Vidyasagar D; Bhat R; Esterly J; Matsuda H; Shimada S; Krukenkamp IB; Shanklin DR
    Crit Care Med; 1990 Apr; 18(4):403-9. PubMed ID: 2318051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.